Carotid Artery Stenosis Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023

The global carotid artery therapeutics market has the potential to grow by USD 333.77 million during 2019-2023. The growth momentum will accelerate throughout the forecast period, and the market will grow at a CAGR of more than 4%.

Growing awareness about carotid artery stenosis and the increasing demand for curative therapies are some of the major factors driving market growth. The US, the UK, and Germany are currently the major markets for carotid artery stenosis therapeutics.

Carotid Artery Stenosis Therapeutics Market Report - Key Insights

Scope of the Report

The report provides a detailed analysis of the market by product and geography. Also, the report analyzes the market’s competitive landscape and offers information on several market vendors.

Browse TOC and LoE with selected illustrations and example pages from carotid artery stenosis therapeutics market report

Request a FREE sample now!

Market Segmentation

Carotid Artery Stenosis Therapeutics Market by Product

• Antithrombotics
• Antihyperlipidemics
• Antihypertensives

Carotid Artery Stenosis Therapeutics Market by Region

• Asia
• Europe
• North America
• ROW

Market Competitive Analysis

The carotid artery stenosis therapeutics market is fragmented, and the degree of fragmentation will increase during the forecast period. The rising prevalence of carotid artery stenosis has induced several vendors to enter the market with low-cost generics with assured safety and efficacy. Amgen Inc., AstraZeneca Plc, and Boehringer Ingelheim International GmbH are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the availability of substitutes will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The report provides information on the production, sustainability, and prospects of several companies, including:

• Amgen Inc.
• AstraZeneca Plc
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi

Carotid Artery Stenosis Therapeutics Market: Key Drivers and Trends

Several awareness programs are being conducted across the world to reduce the prevalence of carotid artery stenosis. Many governments and vendors are initiating multiple awareness and educational programs to increase the knowledge about carotid artery stenosis among people. For instance, the Circulation Foundation in the UK focuses on creating a vascular disease-free society by promoting awareness about vascular conditions and supporting vital researches. The organization’s awareness programs also raise funds, suggest preventing risk factors, and educate people about a healthy diet.

Similarly, the Stroke Awareness Foundation promotes awareness among communities and families about the devastating effects of strokes and carotid artery stenosis. Such awareness programs are increasing patient knowledge about the disease and are encouraging people with high-risk factors to prevent the disease. This is one of the key factors driving global carotid artery stenosis therapeutics market growth.

• Carotid artery stenosis therapeutics market trends such as increasing demand for curative therapies will also influence market growth.
• The high prevalence of carotid artery stenosis and the lack of approved drugs is providing significant growth opportunities for vendors.
• Side-effects associated with off-label drugs is increasing the demand for new curative therapies.
• Patients are shifting their preference toward alternatives such as endarterectomy, angioplasty, and stents for the treatment of carotid artery stenosis.
• However, high cost and risks associated with such procedures will drive patients to opt for safe curative therapies.
• During 2019-2023, the market will register a CAGR of more than 4%.

Carotid Artery Stenosis Therapeutics Market: Segmentation by Region

For more insights on the market share of various regions Request for a FREE sample now!

The rise in risk factors such as high cholesterol levels, smoking, alcohol consumption, high blood pressure, and diabetes have increased the prevalence of carotid artery stenosis in North America. The market in the region is witnessing a rise in the number of approved drugs for the treatment of carotid artery stenosis.

During the forecast period, over 38% of the overall market growth will originate from North America. However, market growth in the region will be slower than the growth of the market in Asia.

Carotid Artery Stenosis Therapeutics Market: Segmentation by Product

Request for a FREE sample and Get more information on the market contribution of various product segments

Antithrombotic drugs are generally used as the first-line option for the treatment of carotid artery stenosis. These drugs prevent the formation of fibrin meshes from fibrin protein and eliminate the trapping of blood cells in blood vessels by making the blood thin.

As a result, the carotid artery stenosis therapeutics market size will increase steadily in the antithrombotic drugs segment during the forecast period. However, market growth in antithrombotic segment will be slower than the growth of the market in antihyperlipidemic segment.

Carotid Artery Stenosis Therapeutics Market: Key Highlights of the Report

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the market during the next five years
• Precise estimation of the global carotid artery stenosis therapeutics market size and its contribution to the parent market
• Accurate carotid artery stenosis therapeutics market forecast on upcoming trends and changes in consumer behavior
• The growth of the carotid artery stenosis therapeutics industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of carotid artery stenosis therapeutics market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch